TNF and alopecia areata: Biologics targeting TNF-α can induce a wide range of immunological responses ranging from IFN-y dominant responses such as vitiligo and alopecia areata (Th1), Th17-mediated skin disorders such as psoriasis and palmoplantar pustulosis but also Th2-induced disorders such as eczema.